Scienmag

SEPTEMBER 23, 2020

These molecular insights may foster effective therapies using existing drugs for patients with COVID-19. Credit: UAB BIRMINGHAM, Ala. – Viral and bacterial pathogens wield pathogenic or virulent proteins that interact with high-value targets inside human cells, attacking what is known as the host interactome.

Protein 85

Protein Drugs Bioinformatics Genetics 85

pharmaphorum

MARCH 28, 2022

AION Labs’ third call for applications seeks computational biologists, bioinformatics and cheminformatics scientists, AI researchers, and antibody or protein engineers at academic and industry research labs worldwide to assemble a fully funded start-up company. From there, they evaluate what kind of antibodies are produced.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

XTalks

MAY 20, 2022

They also assist in the testing of medical devices and development of drug products. There are different fields to explore as a clinical scientist — these include clinical bioinformatics, physiological sciences, pathology, medical physics and more. Genetic Science. What Field Can You Work in as a Clinical Scientist? Hematology.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

Scienmag

MARCH 1, 2021

Screening for predictive factors of drug resistance and tailored therapies can improve outcomes in patients with refractory diffuse large B-cell lymphoma White blood cells or lymphocytes are the soldiers of our immune system that patrol the body via the lymphatic system.

Drugs 75

Drugs Bioinformatics Gene Genetics 75

Scienmag

SEPTEMBER 30, 2020

30, 2020 – Scripps Research chemist Matthew Disney, PhD, and colleagues have created drug-like compounds that, in human cell studies, bind and destroy the pandemic coronavirus’ so-called “frameshifting element” to stop the virus from […].

Engineer 68

Engineer RNA Research Drugs 68

Trialfacts

SEPTEMBER 12, 2024

Must not have a history of alcohol or drug abuse within the past 2 years. Must not have been diagnosed with cancer within the past 5 years, excluding completely treated in situ carcinoma of the cervix, and completely treated and resolved non-metastatic squamous or basal cell carcinoma of the skin or melanoma in situ.

Research 52

Research Gene Editing Biobanking Bioinformatics 52

Scienmag

APRIL 28, 2021

In the Nature current special issue, the research group published another study on the genome of the common marmoset, an important primate model for neurodegenerative diseases, drug […].

Genomics 64

Genomics Genome Research Drugs 64

Scienmag

MARCH 4, 2021

Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful approach to identify potential novel therapeutic targets.

Protein 46

Protein Medicine Drugs Research 46

The Pharma Data

JULY 27, 2021

This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Food and Drug Administration, and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. About Teneobio Teneobio, Inc.

Production 52

Production Antibody Sales Development 52

Worldwide Clinical Trials

APRIL 7, 2025

Solid tumors exhibit genetic variances between patients with a shared diagnosis and within a single patient, even across one tumor. The tumor microenvironment can also impact drug efficacy, while strict eligibility criteria can limit the pool of potential participants, affecting the generalizability of study findings.

Medicine 100

Medicine Research Clinical Trials Clinical Trials 100

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. What, then, is the solution?

Development 135

Development Research Drugs Clinical Trials 135

The Pharma Data

OCTOBER 27, 2020

Food and Drug Administration (FDA) in support of an efficacy supplement to the Tyvaso new drug application (sNDA), which we expect to result in revised labeling reflecting the outcome of the INCREASE study. We submitted a 505(b)(1) new drug application (NDA) to the FDA for our Trevyent disposable treprostinil pump system in June 2019.

Production 40

Production Sales Licensing Licensing 40

pharmaphorum

APRIL 7, 2022

Novartis’ generics unit Sandoz has moved on to the next stage of a collaboration with Ares Genetics, which is focusing on the use of artificial intelligence to track antimicrobial resistance (AMR), improve diagnoses and guide the most effective use of antibiotics. “AMR, which is now estimated to directly account for nearly 1.3

Bioinformatics 52

Bioinformatics Genetics Genome Genomics 52

Roots Analysis

AUGUST 15, 2024

These diagnostic solutions are essential for detecting and monitoring diseases, identifying genetic predispositions, and guiding personalized treatment plans. Molecular diagnostic solutions are pivotal across various medical fields, including oncological disorders, infectious diseases, genetic testing, and personalized medicine.

Marketing 40

Marketing Genetics Genome Genomics 40

XTalks

NOVEMBER 7, 2022

Immunofluorescent staining of CTCs is a CTC isolation method that has been used since the first US Food and Drug Administration (FDA) approval in 2013 for the CellSearch ® CTC enumeration platform. Optimal methods for bioinformatic analysis are still needed. percent show less reliability).

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

XTalks

DECEMBER 13, 2023

3) Fulgent Genetics Compound annual growth rate: 260 percent Fulgent Genetics, headquartered in California, is a technology-driven company with a strong presence in clinical diagnostics and therapeutic development. This substantial investment is accelerating the growth of their new drug pipeline. million and $38.8

Genetics 111

Genetics Vaccine Vaccination DNA 111

The Pharma Data

MAY 22, 2023

Pathogen genomics analyzes the genetic code of viruses, bacteria and other disease-causing organisms to understand how infectious they are, how deadly they are, and how they spread. Its use in monitoring the spread of HIV drug resistance, for example, has led to antiretroviral regimes that have saved countless lives.

Genome 52

Genome Genomics Bioinformatics Bacteria 52

STAT News

MARCH 6, 2023

Unlike most people who receive medications yet to be cleared by the Food and Drug Administration, none of these patients is getting the vaccines as part of a clinical trial. Instead, the 26 patients paid the foundation to create the vaccines and provide them through the FDA’s expanded access program.

Vaccine 98

Vaccine Vaccination Drugs Clinical Trials 98

The Pharma Data

JANUARY 10, 2021

I actually think neuroscience is going to heat up in 2021,” said Ben Zeskind , co-founder and CEO of Immuneering , which is using bioinformatics and computational biology to develop new drugs in this space, along with oncology and immuno-oncology. They tell you, ‘that’s a drug that saves us from the coronavirus.’

Vaccine 52

Vaccine Vaccination Regulation Drugs 52